SAREPTA THERAPEUTICS INC
353 institutions still hold SAREPTA THERAPEUTICS INC as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
Sarepta Therapeutics shows an unusually thin institutional footprint in this snapshot: only three reported holders account for about .9K of 13F value, led by Versant Capital Management at roughly 74% of the tracked book, MassMutual Private Wealth & Trust near 22%, and Cedar Mountain Advisors around 4%. The sharp signal is not accumulation but retreat: Versant cut its stake from 646 to 450 shares, while MassMutual added just 34 shares and Cedar Mountain held flat, leaving ownership concentrated in micro-positions rather than broad institutional sponsorship.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.